3,359 Shares in MetLife, Inc. (NYSE:MET) Acquired by W Advisors LLC

W Advisors LLC bought a new position in shares of MetLife, Inc. (NYSE:METFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,359 shares of the financial services provider’s stock, valued at approximately $222,000.

Several other institutional investors have also recently made changes to their positions in MET. Benjamin F. Edwards & Company Inc. raised its position in shares of MetLife by 36.4% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 11,114 shares of the financial services provider’s stock worth $735,000 after buying an additional 2,966 shares in the last quarter. Silver Lake Advisory LLC raised its position in shares of MetLife by 0.5% in the fourth quarter. Silver Lake Advisory LLC now owns 74,701 shares of the financial services provider’s stock worth $4,940,000 after buying an additional 368 shares in the last quarter. LGT Group Foundation purchased a new stake in shares of MetLife in the fourth quarter worth $214,000. First Trust Direct Indexing L.P. raised its position in shares of MetLife by 20.3% in the fourth quarter. First Trust Direct Indexing L.P. now owns 17,709 shares of the financial services provider’s stock worth $1,171,000 after buying an additional 2,986 shares in the last quarter. Finally, Great Valley Advisor Group Inc. raised its position in shares of MetLife by 1.9% in the fourth quarter. Great Valley Advisor Group Inc. now owns 8,898 shares of the financial services provider’s stock worth $588,000 after buying an additional 167 shares in the last quarter. Hedge funds and other institutional investors own 89.81% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Bill Pappas sold 27,000 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the transaction, the executive vice president now owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, insider Ramy Tadros sold 4,026 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the transaction, the insider now owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the transaction, the executive vice president now owns 57,768 shares of the company’s stock, valued at $4,174,893.36. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Keefe, Bruyette & Woods increased their price objective on MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. Morgan Stanley increased their target price on MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Monday, April 15th. The Goldman Sachs Group raised MetLife from a “neutral” rating to a “buy” rating and increased their target price for the company from $70.00 to $80.00 in a research note on Monday, January 8th. Piper Sandler lifted their price objective on MetLife from $74.00 to $85.00 and gave the stock an “overweight” rating in a report on Friday, April 5th. Finally, UBS Group dropped their target price on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a report on Monday, February 5th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $79.23.

Get Our Latest Research Report on MET

MetLife Stock Up 0.4 %

Shares of MET stock traded up $0.28 during midday trading on Friday, reaching $70.52. 3,361,215 shares of the stock were exchanged, compared to its average volume of 3,164,878. MetLife, Inc. has a 1 year low of $48.95 and a 1 year high of $74.68. The company’s 50 day moving average is $71.66 and its two-hundred day moving average is $67.45. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.58. The firm has a market cap of $50.29 billion, a PE ratio of 24.23, a price-to-earnings-growth ratio of 0.53 and a beta of 1.03.

MetLife (NYSE:METGet Free Report) last posted its earnings results on Wednesday, May 1st. The financial services provider reported $1.83 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.83. MetLife had a return on equity of 20.39% and a net margin of 3.50%. The firm had revenue of $17.02 billion for the quarter, compared to the consensus estimate of $17.73 billion. During the same quarter in the prior year, the business earned $1.52 EPS. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, equities research analysts predict that MetLife, Inc. will post 8.69 EPS for the current year.

MetLife declared that its Board of Directors has authorized a share repurchase program on Wednesday, May 1st that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to repurchase up to 6% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.

MetLife Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 11th. Shareholders of record on Tuesday, May 7th will be issued a dividend of $0.545 per share. This is an increase from MetLife’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, May 6th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.09%. MetLife’s dividend payout ratio is 71.48%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.